Full-Time Academic Malignant Hematologist

Save
You need to sign in or
create an account to save a job.

Full-Time Academic Malignant Hematologist, Division of Medical Oncology and Hematology
Princess Margaret Cancer Centre, University Health Network and Sinai Health System
Clinician Investigator/ Clinician Teacher/ Clinician in Quality & Innovation
Assistant/Associate/Full Professor

The Department of Medicine in the Temerty Faculty of Medicine at the University of Toronto invites applications for full-time faculty positions.  The appointment will be with the Division of Medical Oncology and Hematology, University Health Network and Sinai Health.  The Division of Medical Oncology and Hematology is seeking to recruit an exceptional Academic Malignant Hematologist. The successful applicant should be eligible for a clinical academic appointment at the rank of Assistant Professor or higher, at the University of Toronto and, will be expected to work in the position description of either Clinician Investigator, Clinician Teacher or Clinician in Quality & Innovation.  The anticipated start date is August 01, 2024, or shortly thereafter.  There are potential opportunities to work within different disease sites; however, the program is currently looking for an innovative Hematologist with special interest or expertise in Leukemia.

The successful applicant will have a demonstrated passion for the medical care of cancer patients as well as a strong interest in teaching and/or quality improvement.  The successful applicant will have a passion for complex in-patient management, overall cancer care and early phase clinical trials. The successful applicant will join a multidisciplinary team in the management of patients with hematologic malignancies and will work in collaboration with the clinical genomics and clinical trials programs, within a comprehensive cancer centre setting.  In addition, the successful candidate will be expected to engage in clinical, translational, or basic research. Other responsibilities include teaching at the undergraduate and postgraduate levels.

For applicants being considered for appointment as a Clinician Teacher, excellence will be assessed by the presence of scholarly contributions to teaching and education as evidenced by pedagogical innovation, curriculum development, experience in teaching at the undergraduate and graduate level, and teaching awards. For Clinician Investigator, scholarly excellence will be assessed by the presence of research grants, publications in leading journals, invited presentations at significant conferences, awards, accolades, and other related accomplishments. For Clinician in Quality and Innovation, excellence will be assessed by advanced training in quality improvement or equivalent, successful quality improvement initiatives, evidence of practice and/or equipment innovations, and invitations to significant conferences, and accolades.

All candidates must be able to function proficiently in English, hold an MD, FRCPC qualifications or, the equivalent thereto and, have Malignant Hematologist (or equivalent) specialist designation.  Candidates should be certified or eligible for certification by the Royal College of Physicians and Surgeons of Canada or, have comparable qualifications.  Candidates must hold, or be eligible for licensure with the College of Physicians and Surgeons of Ontario.  The successful applicant must also obtain and maintain privileges at University Health Network and Sinai Health System. 

Academic rank, salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate.  A highly attractive remuneration package is available and the successful candidate will be eligible for medical and dental benefits.

Ranked in the top 10 on Newsweek’s list of the World’s Best Specialized Hospitals for Oncology in 2023, the Princess Margaret Cancer Centre continues to be on the frontiers of medical, surgical and radiation oncology, embracing the latest technology and international best-practices and setting standards for patient care.  The Princess Margaret Cancer Centre includes the Princess Margaret Cancer Research Institute, while Sinai Health includes the Lunenfeld-Tanenbaum Research Institute. These are world-class basic and translational research institutes with particular strengths in Genomics, Immunology, Stem Cell Biology, Cancer Biology, and Cell Therapeutics. The close association between clinicians and scientists within both institutions provides the opportunity for collaborations on disease biology and the development of innovative and informative translational studies, allowing the applicant to achieve the goal of bench-to-bedside medicine. In addition, Princess Margaret Cancer Centre and Sinai Health support active and widely recognized clinical trials and drug development programs and maintains a state-of-the-art GMP cell processing facility. Both institutions are affiliated with the University of Toronto, which is world-recognized for programs in areas including Biochemistry, Immunology, Stem Cell Biology, Genomics, Proteomics, and Cell Processing, among others. Both Princess Margaret Cancer Centre and Sinai Health are teaching hospitals, dedicated to educating the world’s future top cancer experts. Our role as internationally respected teaching hospitals keeps us and our students abreast of the latest medical developments and the most advanced technology. 

The Leukemia Site Group at Princess Margaret is the largest program of its kind in Canada and one of the largest in North America. It is the only comprehensive leukemia program in the Greater Toronto Area. With a team of over 40 staff and the largest inpatient leukemia unit in the country, our group assesses and treats adults with acute and chronic leukemias, myelodysplastic syndromes and myeloproliferative neoplasms. We provide cutting-edge and novel treatment options. Our internationally recognized inter-professional team consists of hematologists, medical oncologists, nurse practitioners, nurses and other allied health professionals. Committed to excellence in comprehensive patient care, the team works collaboratively to consider each patient’s individual needs and circumstances throughout the cancer experience, while also advancing a major focus on leukemia research and education with the goal of improving leukemia diagnosis and treatment. Not only is the leukemia program recognized for ground-breaking basic leukemia research, but our clinical trials program is the most comprehensive in the country, with our staff taking a leadership role in designing and conducting Phase I, II, and international Phase III trials designed to change practice in the management of leukemia. ​

Should you be interested in this exciting opportunity, please forward your covering letter, curriculum vitae, and the names and addresses of three (3) referees to:

Dr. Amit Oza - Chief, Division of Medical Oncology and Hematology
C/o Michelle Williams – Administrative Manager
Princess Margaret Cancer Centre, University Health Network
Suite 7-925, 700 University Avenue, Toronto, Ontario, Canada, M5G 1Z5
Tel: 416.946.2341 Fax: 416.946.2082 E-mail: michelle.williams@uhn.ca   

Application Deadline will remain open until the positions are filled.

For more information on the Princess Margaret Cancer Centre and our world-recognized programs, visit: www.theprincessmargaret.ca   

For more information on Sinai Health and our world-renowned programs, visit:

https://mountsinai.on.ca/  

For more information about the Department of Medicine at the University of Toronto, please visit our website at https://www.deptmedicine.utoronto.ca. The Department of Medicine’s academic position descriptions can be viewed on this webpage: https://www.deptmedicine.utoronto.ca/academic-position-descriptions#AcademicPositionDescriptions.

All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.

Diversity Statement

The University of Toronto, University Health Network and Sinai Health System are strongly committed to diversity within its community and especially welcomes applications from racialized persons/persons of colour, women, Indigenous / Aboriginal People of North America, persons with disabilities, LGBTQ2S+ persons, and others who may contribute to the further diversification of ideas.

Accessibility Statement

The University strives to be an equitable and inclusive community, and proactively seeks to increase diversity among its community members. Our values regarding equity and diversity are linked with our unwavering commitment to excellence in the pursuit of our academic mission.  The University is committed to the principles of the Accessibility for Ontarians with Disabilities Act (AODA). As such, we strive to make our recruitment, assessment and selection processes as accessible as possible and prove accommodations as required for applicants with disabilities.  If you require any accommodations at any point during the application and hiring process, please contact [email protected]